• Explore /
  • Poster
  • / Antitumor activity of T cells expressing a novel anti-folate receptor alpha (FOLR1) costimulatory antigen receptor (CoStAR) in a human xenograft murine solid tumor model and implications for in-human studies.

Antitumor activity of T cells expressing a novel anti-folate receptor alpha (FOLR1) costimulatory antigen receptor (CoStAR) in a human xenograft murine solid tumor model and implications for in-human studies.

Abstract Video & Slides Poster

Authors

null

Owen R. Moon

Instil Bio, Inc., Dallas, TX

Owen R. Moon , Yun Qu , Michael G. King , Michelle Mojadidi , Cynthia Chauvin-Fleurence , Clare Yarka , Alicia Evans , Xingliang Zhou , Tania (Theoni) Katopodi , Akshata Udyavar , John S. Bridgeman , Gray Kueberuwa , Rubén Alvarez-Rodríguez

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Cellular Immmunotherapy

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 2535)

DOI

10.1200/JCO.2022.40.16_suppl.2535

Abstract #

2535

Poster Bd #

190

Abstract Disclosures

Similar Posters

First Author: Michelle R. Abelson

First Author: Suzanne Phillips

First Author: Eugenia Girda

First Author: Penghui Xing